|
|
|
| Monday,
November 11th |
|
|
|
|
|
08.30-08.45 |
Welcome
address and Introduction to Day 1
Nils
Gunnar Wahlgren |
|
|
08.45-09.50 |
Session:
Carotid Surgery
Chairpersons:
Charles Warlow, Edinburgh, and Jesper Swedenborg,
Stockholm
|
|
|
08.45-09.05 |
Estimating
the risks and benefits of carotid endarterectomy
Peter
Rothwell, Oxford |
|
|
09.05-09.20 |
Duplex criteria for high grade
internal carotid artery stenosis
Tomas Jogestrand, Stockholm |
|
|
09.20-09.35 |
Evaluation of postoperative
events - Swedish experiences
David
Bergqvist, Uppsala |
|
|
09.35-09.50 |
Consensus
discussion and statement |
|
|
09.50-10.20 |
Coffee break |
|
|
10.20-10.50 |
Special
Lecture:
Chairpersons:
Nils Gunnar Wahlgren, Stockholm & Hans-Göran
Hårdemark, Stockholm |
|
|
|
Management
of haemorrhagic stroke
Thorsten
Steiner, Heidelberg |
|
|
10.50-12.30 |
Session: Antiplatelet therapy for Stroke Prevention
Chairpersons: Hans-Göran Hårdemark, Stockholm and
Gudrun Boysen, Copenhagen |
|
|
10.50-11.15 |
Antiplatelet
therapy and stroke: results from the Antithrombotic
Trialists Collaboration.
Cathie
Sudlow, Edinburgh |
|
|
11.15-11.40 |
Evidence of antithrombotic
treatment
Louis
R. Caplan, Boston |
|
|
11.40-11.55 |
Effect
of clopidogrel in high risk patients
Markku Kaste, Helsinki |
|
|
11.55-12.10 |
Dipyridamole
and headache - does dose titration help?
Arne
Lindgren, Lund |
|
|
12.10-12.30 |
Consensus
discussion and statement |
|
|
12.30-13.25 |
Lunch
and Poster Exhibition |
|
| 13.25-14.40 |
Session:
Blood pressure and cholesterol lowering for Stroke
Prevention
Chairpersons:
Jan Lodder, Maastricht, and Bo Norrving, Lund
|
|
|
13.25-13.45 |
ACE
inhibitor perindopril for secondary prevention of stroke -
results from the PROGRESS study
Andreas
Terent, Uppsala |
|
|
13.45-14.05 |
ACE
inhibitor ramipril for prevention of stroke - results from
the HOPE study Jan
Östergren, Stockholm |
|
|
14.05-14.25 |
MRC/BHF
Heart Protection Study: Effects in over 6000 patients with
history of stroke or TIA
Rory
Collins, Oxford |
|
|
14.25-14.55 |
Coffee
Break |
|
|
14.55-15.25 |
Special
Lecture:
Chairpersons:
Nils Gunnar Wahlgren, Stockholm and Niaz Ahmed, Stockholm |
|
|
|
Stop
measuring blood pressure and cholesterol
Charles
Warlow, Edinburgh |
|
|
15.25-16.45 |
Session:
The complexity of possibilities: who should receive what?
Chairpersons:
Bo Norrving, Lund and Jan Lodder, Maastricht |
|
|
15.25-15.45 |
What
would I give my next TIA patient?
Markku
Kaste, Helsinki |
|
|
15.45-16.05 |
Is
it worth the cost?
Kjell
Asplund, Umeå |
|
|
16.05-16.35 |
Panel
consensus discussion and statement |
|
|
16.35-16.45 |
Summary
of the first day's discussions
Nils
Gunnar Wahlgren, Stockholm |
|
|
16.50-18.40 |
SITS International:
SITS-MOST Steering Committee meeting |
|
|
19.00 |
Dinner
at the Hall of Mirrors, Grand Hotel, Stockholm |
|
|
|
|
|
|
Tuesday,
November 12th |
|
|
|
|
|
|
08.30-08.45 |
Introduction
to Day 2
Nils
Gunnar Wahlgren, Stockholm |
|
|
08.45-09.45 |
Session:
Ongoing trials
Chairpersons:
Martin Grond, Cologne and Angel Chamorro, Barcelona |
|
|
08.45-9.00 |
Ongoing
trials in stroke prevention
Nils
Gunnar Wahlgren. Stockholm |
|
|
9.00-09.15 |
Ongoing
trials on anticoagulation and thrombolysis in acute stroke
Angel
Chamorro, Barcelona |
|
|
09.15-09.30 |
Ongoing
trials on neuroprotectants in acute stroke
Jan
Lodder, Maastricht |
|
|
09.30-09-45 |
Ongoing
trials in stroke rehabilitation and recovery
Gudrun
Boysen, Copenhagen |
|
|
09.45-10.15 |
Coffee
break |
|
|
10.15-11.35 |
Session:
Rehabilitation and recovery after stroke
Chairpersons:
Per Wester, Umeå and Philip Bath, Nottingham |
|
|
10.15-10.35 |
Functional
brain imaging evidence of brain plasticity
Jean-Claude
Baron, Cambridge |
|
|
10.35-10.55 |
Amphetamines
and stroke recovery
Louise
Martinsson, Stockholm |
|
|
10.55-11.15 |
What
do stroke units do for recovery?
Bent
Indredavik, Trondheim |
|
|
11.15-11.35 |
Consensus
discussion and statement |
|
|
11.35-12.05 |
Special
Lecture:
Chairpersons:
Nils Gunnar Wahlgren, Stockholm, and Louise Martinsson,
Stockholm |
|
|
|
Worsening
stroke Louis
R Caplan, Boston |
|
|
12.05-13.00 |
Lunch
and poster exhibition |
|
|
13.00-14.55 |
Session:
Thrombolysis in acute stroke
Chairpersons:
Markku Kaste, Helsinki, and Kennedy R Lees, Glasgow |
|
|
13.00-13.20 |
Updated
systematic review of randomised controlled trials pf rt-PA
in acute stroke - when is enough enough?
Joanna
Wardlaw, Edinburgh |
|
|
13.20-13.35 |
SITS
and the European Union Licence for rt-PA in acute stroke
Nils
Gunnar Wahlgren, Stockholm |
|
|
13.35-13.55 |
Thrombolysis
in Bergen - a Norwegian perspective Lars
Thomassen, Bergen |
|
|
13.55-14.15 |
Experiences
from heparin treatment following thrombolysis
Jan
Sobesky, Cologne |
|
|
14.15-14.35 |
Cerebral
haemorrhage following thrombolysis in stroke
Rüdiger
von Kummer, Dresden |
|
|
14.35-14.55 |
Consensus
discussion and statement |
|
|
14.55-15.25 |
Coffee
break |
|
|
15.25-17.00 |
Session:
The role of blood pressure and non-pharmacological issues in
acute stroke
Chairpersons:
Arne Lindgren, Lund & Hans-Göran Hårdemark, Stockholm |
|
|
15.25-15.45 |
Blood
pressure in acute stroke - an update
Philip
Bath, Nottingham |
|
|
15.45-16.05 |
Hemicraniectomy
Thorsten
Steiner, Heidelberg |
|
|
16.05-16.25 |
Cooling
in acute stroke
Thorsten
Steiner, Heidelberg |
|
|
16.25-16.45 |
Ultrasound
in acute stroke
Michael Daffertshofer,
Mannheim |
|
|
16.45-17.00 |
Summary
and closing statement
Nils
Gunnar Wahlgren, Stockholm |
|
|
|
|
|
|
|
|
|